|
|
Published: 01 November 2019
|
|
|
|
|
[1] 李爱芳,丁卉,丁茂文,等. 鲍曼不动杆菌耐药性分析[J]. 浙江预防医学,2014,26(3):288-289. [2] 吕青青,彭敏飞,张维溪. 455株耐碳青霉烯鲍曼不动杆菌耐药性分析[J]. 浙江预防医学,2016,28(6):616-618. [3] 陈艺升,高晶,张灏昊,等. 质粒倡介导的blaOXA-23耐药基因研究[J]. 中华检验医学杂志,2017,40(1):36-40. [4] Clinical and Laboratory Standards Institute(CLSI). Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI supplement M100[S]. 2017. [5] JONES R N,FERRARO M J,RELLER L B,et al. Multicenter studies of tigecycline disk diffusion susceptibility tests:results for Acinetobacter spp.[J]. J Clin Microbiol,2007,45:227-230. [6] Clinical and Laboratory Standards Institute(CLSI). Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100[S]. 2018. [7] GAO J,ZHAO X,BAO Y,et al. Antibiotic resistance and OXA-type carbapenenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards[J]. Burns,2014,40(2):295-299. [8] 王露露,郑英俊,郭振辉,等. 呼吸机相关性肺炎患者血与痰标本中分离的鲍曼不动杆菌分子流行病学分析[J]. 中国感染与化疗杂志,2018,18(1):58-63. [9] 宋晓萍,陈佳红,翟军清,等. 青岛地区重症监护病房分离的鲍曼不动杆菌耐药特征及碳青霉烯基因型的研究[J]. 中华检验医学杂志,2017,40(3):216-220. [10]卜劲松,王勇. 耐碳青霉烯类药物鲍曼不动杆菌的碳青霉烯酶、整合酶基因研究[J]. 检验医学,2015,30(6):626-630. [11]KARAN N,SUNDSFJORD A,TOWNER K,et al. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii[J]. Drug Resist Updat,2012,15(4):707-712. [12]杨青,周志慧,符一骐. 浙江省碳青霉烯类抗生素耐药鲍曼不动杆菌多位点序列分型研究[J]. 中华检验医学杂志,2013,36(4):303-306. |
[1] |
. [J]. Preventive Medicine, 2021, 33(12): 1256-1259. |
|
|
|
|